Directory
>
Emma Mcburney
Emma Mcburney
Vice President, Head of Business Development and M&A | Biogen
Boston, Massachusetts, United States
Emma Mcburney
Summary
Emma McBurney is a seasoned business development executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Vice President and Head of Business Development and M&A at Biogen, she has a proven track record of leading high-stakes negotiations and executing complex deals that have significantly advanced the company's research pipeline. With an MBA from Yale and a background in finance, Emma adeptly combines analytical rigor with strategic vision. Her leadership has resulted in over 50 business development deals worth more than $4 billion between 2020 and 2022. Emma's previous roles include key positions at Sanofi Genzyme and Boston Scientific, where she honed her expertise in mergers and acquisitions. She is passionate about fostering innovation and driving growth in the healthcare industry.
Emma Mcburney
Work Experience
Vice President, Head of Business Development and M&A at
Biogen
January 2021 - Present
Board Observer at
ReNetX Bio
January 2020 - Present
Executive Director, Business Development & Licensing at
Biogen
October 2019 - April 2021
Head of Business Development & Licensing, Rare Diseases at
Sanofi
December 2017 - September 2019
Associate Director, Business Development at
Sanofi
March 2016 - December 2017
Manager, Strategy & Business Development at
SANOFI-AVENTIS AUSTRALIA PTY LTD
September 2014 - May 2016
Manager, Corporate Business Development at
Boston Scientific
October 2011 - August 2014
Sr. Financial Analyst, Corporate FP&A at
Boston Scientific
January 2009 - October 2011
Analyst, Business Transactions, WW Financial Reporting at
Boston Scientific
July 2007 - January 2009
Emma Mcburney
Education
Yale University - Yale School of Management, Master Of Business Administration (M.B.A.)
January 2016 - January 2018
Babson College, B.S. In Business Management
Frequently Asked Questions about Emma Mcburney
What is Emma Mcburney email address?
Emma Mcburney's primary email address is *************@biogen.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Emma Mcburney work for?
Emma Mcburney is a Vice President, Head of Business Development and M&A at Biogen, a company specializing in Commercial physical research.
Where Emma Mcburney graduated from?
Emma Mcburney holds a degree in from Yale University - Yale School of Management.
How can I directly contact Emma Mcburney?
To contact Emma Mcburney directly, you can use the email address *************@biogen.com. Complete contact information is available upon registration with Muraena.
Who is Emma Mcburney?
Emma McBurney is a seasoned business development executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Vice President and Head of Business Development and M&A at Biogen, she has a proven track record of leading high-stakes negotiations and executing complex deals that have significantly advanced the company's research pipeline. With an MBA from Yale and a background in finance, Emma adeptly combines analytical rigor with strategic vision. Her leadership has resulted in over 50 business development deals worth more than $4 billion between 2020 and 2022. Emma's previous roles include key positions at Sanofi Genzyme and Boston Scientific, where she honed her expertise in mergers and acquisitions. She is passionate about fostering innovation and driving growth in the healthcare industry.
Emma`s contact details
*************@biogen.com
Colleagues
Chief Commercial & International Counsel
Executive Vice President, Head of Pharmaceutical Operations and Technology (PO&T)
VP, Head of US Specialty Marketing
Executive Director, Corporate Controller
General Manager / Managing Director Belgium and Netherlands
Vice President Human Resources, Europe, Canada and Partner Markets
Chief US Commercial Counsel
Chief Privacy Officer, Head of Privacy and Data Protection
Chief of Staff to EVP of Technology and Business Solutions
Vice President/Head of Biologics Drug Discovery